Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
To create leading company developing medicines targeting metalloenzymes
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
Having a healthy gut is key as it permits the body to build a stronger immune system
Upon approval, XPHOZAH would be the first and only phosphate absorption inhibitor, offering patients a novel mechanism
Subscribe To Our Newsletter & Stay Updated
